WallStSmart

The Clorox Company (CLX)vsKimberly-Clark Corporation (KMB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kimberly-Clark Corporation generates 145% more annual revenue ($16.56B vs $6.76B). KMB leads profitability with a 12.8% profit margin vs 11.2%. KMB appears more attractively valued with a PEG of 2.07. KMB earns a higher WallStSmart Score of 58/100 (C).

CLX

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 8.0Value: 4.7Quality: 6.5
Piotroski: 5/9Altman Z: 2.07

KMB

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 8.0Value: 4.0Quality: 4.0
Piotroski: 3/9Altman Z: 2.19
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLXSignificantly Overvalued (-22.9%)

Margin of Safety

-22.9%

Fair Value

$102.51

Current Price

$94.14

$8.37 premium

UndervaluedFair: $102.51Overvalued
KMBSignificantly Overvalued (-36.3%)

Margin of Safety

-36.3%

Fair Value

$78.97

Current Price

$99.04

$20.07 premium

UndervaluedFair: $78.97Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLX3 strengths · Avg: 9.3/10
Return on EquityProfitability
54.6%10/10

Every $100 of equity generates 55 in profit

Debt/EquityHealth
-66.9610/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.7x8/10

Attractively priced relative to earnings

KMB1 strengths · Avg: 10.0/10
Return on EquityProfitability
118.0%10/10

Every $100 of equity generates 118 in profit

Areas to Watch

CLX4 concerns · Avg: 3.5/10
PEG RatioValuation
2.204/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.1%4/10

0.1% revenue growth

EPS GrowthGrowth
2.7%4/10

2.7% earnings growth

Free Cash FlowQuality
$-165.00M2/10

Negative free cash flow — burning cash

KMB4 concerns · Avg: 3.8/10
PEG RatioValuation
2.074/10

Expensive relative to growth rate

Price/BookValuation
18.3x4/10

Trading at 18.3x book value

Revenue GrowthGrowth
2.7%4/10

2.7% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CLX

The strongest argument for CLX centers on Return on Equity, Debt/Equity, P/E Ratio.

Bull Case : KMB

The strongest argument for KMB centers on Return on Equity.

Bear Case : CLX

The primary concerns for CLX are PEG Ratio, Revenue Growth, EPS Growth.

Bear Case : KMB

The primary concerns for KMB are PEG Ratio, Price/Book, Revenue Growth. Debt-to-equity of 3.94 is elevated, increasing financial risk.

Key Dynamics to Monitor

CLX carries more volatility with a beta of 0.55 — expect wider price swings.

KMB is growing revenue faster at 2.7% — sustainability is the question.

KMB generates stronger free cash flow (321M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KMB scores higher overall (58/100 vs 57/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Clorox Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Kimberly-Clark Corporation

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kimberly-Clark Corporation is an American multinational personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.

Visit Website →

Want to dig deeper into these stocks?